Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog



Cx43 as a target for improved wound healing

15 Oct 03

Worldwide, 95 million people suffer from wounds that result in tissue loss. Wound healing problems extend hospital stays, especially in the elderly, resulting in an additional $1.5 billion in healthcare costs in the US alone. LeadDiscovery’s current target of the month focuses on connexin43, blocking of which produces a dramatic improvement in wound healing. In this feature we also describe how antisense technology has been applied to develop a licensing opportunity in this area

Global pharmaceutical parallel trade: Can it ever happen?

15 Oct 03

One of the most controversial issues in international healthcare is the practice of parallel trade of pharmaceuticals. Parallel trade, sometimes known as the 'grey market', involves the cross border trade in a given product in parallel to a manufacturer's official main supply chain in that country.
Nathan Jessop

Pharma NewsBytes - Oct 13

15 Oct 03

Pharma NewsBytes is LeadDiscovery’s selection of recent press releases for the drug development. Currently featured news items include those announcing promising clinical data for Antigenics' pancreatic cancer Oncophage vaccine; FDA backing for Forest's new Alzheimer's disease drug, Memantine; early figures on the sale of AstraZeneca's anti-cholerstremic drug Crestor; and FDA approval of Pfizer's potential blockbuster, Inspira for the treatment of congestive heart failure

Puppet, partner or parasite?

14 Oct 03

The role of clinical recruitment agencies may be perceived in different ways, but there is a clear demand for expertise delivered in an open and transparent fashion. Agencies must therefore work in partnership, not in parallel, with customers.
Sylvia Kempsell

Emerging Drug Discovery Targets

01 Oct 03

"Emerging Drug Discovery Targets" summarizes the most exciting breaking information recently featured by the pharmaceutical analysts, LeadDiscovery. This edition explores recent advances in the use of siRNA technology in oncology, new molecular targets for the treatment of diabetes and advances in the development of GSK-3 inhibitors. Recent preselected press releases are also highlighted and as usual new licensing opportunities, breaking publications and new industry reports are all identified.

Development of Glycogen synthase kinase-3 (GSK-3) inhibitors by GlaxoSmithKline and by Johnson & Johnson (Target of the Month, TherapeuticAdvances, September, 2003)

25 Sep 03

Proof of concept studies have accumulated supporting the targeting of glycogen synthase kinase-3 (GSK-3) for the treatment of diabetes and CNS conditions. Now inhibitors are emerging as therapeutic candidates

Ghrelin: Pharmaceutical & Therapeutic Opportunities for the Treatment of Obesity

23 Sep 03

"Ghrelin: Pharmaceutical & Therapeutic Opportunities for the Treatment of Obesity" represents a cutting edge analysis of why and how ghrelin should be targeted for the identification of new therapies for obesity

Drug Rep Success - Book review

16 Sep 03

‘Drug Rep Success’ is the most complete of the numerous books published in the last 18 months or so that purport to offer guidance to the wannabe Medical Sales Rep and enhance the productivity of the established rep.
Mark Stacey

Why Corporate Images Need More Than A Quick Face Lift

15 Sep 03

As businesses start to get ready for the next up-cycle, new Names Identities and Images are underway. Big time branding failures and silly naming of the recent past taught marketers some key lessons. Here, is a quick guide to test any Name Identity in use or being planned for the upswing.
Naseem Javed

Winning through the web

09 Sep 03

Pharmiweb's first online recruitment training day saw a group of seasoned recruiters and HR professionals studying and workshopping ideas for more effective online recruitment in a one day session.
Mark Stacey

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.